Published in J Clin Virol on November 10, 2009
Youth-specific considerations in the development of preexposure prophylaxis, microbicide, and vaccine research trials. J Acquir Immune Defic Syndr (2010) 1.24
Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women. J Infect Dis (2012) 0.89
Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination. Hum Vaccin Immunother (2012) 0.82
Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer. Sci Rep (2016) 0.75
Frequency and genotype distribution of multiple human papillomavirus infections in cancer of the head and neck in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.99
Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer (2005) 1.40
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy. Clin Cancer Res (2003) 1.30
Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response. Viruses (2013) 0.99
Abnormal distribution of E-cadherin and beta-catenin in different histologic types of cancer of the uterine cervix. Gynecol Oncol (2005) 0.98
E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway. Virology (2008) 0.92
Geographical variation in human papillomavirus prevalence in Mexican women with normal cytology. Int J Infect Dis (2010) 0.90
Autocrine/paracrine erythropoietin signalling promotes JAK/STAT-dependent proliferation of human cervical cancer cells. Int J Cancer (2011) 0.90
Human papilloma virus in oral squamous cell carcinoma in a Mexican population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2005) 0.90
Trichomonas vaginalis: characterization of a 39-kDa cysteine proteinase found in patient vaginal secretions. Exp Parasitol (2004) 0.89
The modulation of apoptosis by oncogenic viruses. Virol J (2013) 0.89
A great diversity of Amerindian mitochondrial DNA ancestry is present in the Mexican mestizo population. J Hum Genet (2009) 0.88
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study. Virol J (2007) 0.87
Detection of antibodies against a human papillomavirus (HPV) type 16 peptide that differentiate high-risk from low-risk HPV-associated low-grade squamous intraepithelial lesions. J Gen Virol (2004) 0.84
HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers. Expert Opin Ther Targets (2013) 0.82
Functional implication of sequence variation in the long control region and E2 gene among human papillomavirus type 18 variants. Arch Virol (2009) 0.81
Intratypic changes of the E1 gene and the long control region affect ori function of human papillomavirus type 18 variants. J Gen Virol (2012) 0.81
[Usefulness of combining universal oligonucleotides in detecting human papillomavirus in cervical cancer and premalignant lesions]. Salud Publica Mex (2004) 0.81
Hypoxia inducible factor-1α induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL. Leuk Lymphoma (2012) 0.81
Frequent alterations of the beta-catenin protein in cancer of the uterine cervix. Tumour Biol (2002) 0.81
IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects. Cancer Invest (2014) 0.80
The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet (2012) 0.79
Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccine. Clin Diagn Lab Immunol (2004) 0.78
Human papilloma virus and esophageal carcinoma in a Latin-American region. World J Gastroenterol (2009) 0.78
Adjuvants in tuberculosis vaccine development. FEMS Immunol Med Microbiol (2009) 0.78
Abnormal distribution of hDlg and PTEN in premalignant lesions and invasive cervical cancer. Gynecol Oncol (2011) 0.77
Molecular evaluation of the prevalence of oncogenic human papillomavirus genotypes in cervical acetowhite lesions. Intervirology (2002) 0.77
Binding of human papillomavirus type 16 to heparan sulfate is inhibited by mucosal antibodies from patients with low-grade squamous intraepithelial lesions but not from cervical cancer patients. FEMS Immunol Med Microbiol (2008) 0.76
Peripheral blood lymphocytes from low-grade squamous intraepithelial lesions patients recognize vaccine antigens in the presence of activated dendritic cells, and produced high levels of CD8 + IFNγ + T cells and low levels of IL-2 when induced to proliferate. Infect Agent Cancer (2012) 0.76
Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-β. Cancer Immunol Immunother (2015) 0.75
The role of head and neck cancer anatomic subsites when evaluating HPV prevalence - reply. Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.75
Detection of autoantibodies to survivin in cervical mucus from patients with human papillomavirus-associated cervical cancer and precursor lesions. Autoimmunity (2007) 0.75
Triple secondary neoplasms: penis, lip and oral cavity in an AIDS patient treated with pegylated liposomal doxorubicin for cutaneous Kaposi's sarcoma. AIDS (2014) 0.75
[T lymphocyte immunotherapy in patients with cancer]. Cir Cir (2003) 0.75
Bioconversion of Agave tequilana fructans by exo-inulinases from indigenous Aspergillus niger CH-A-2010 enhances ethanol production from raw Agave tequilana juice. J Ind Microbiol Biotechnol (2012) 0.75
[High-risk human papilloma virus and cervical intraepithelial neoplasia in women at 2 hospitals in Mexico City]. Rev Invest Clin (2002) 0.75